Medtronic reports promising two-year BMP (Bone Morphogenetic Protein) data
This article was originally published in Clinica
Executive Summary
Two-year results from Medtronic's large-scale clinical trial of its genetically engineered bone-growth protein in spinal surgery have shown promise for the technology.